Skip to main content
Clinical Trials/NCT02408094
NCT02408094
Unknown
Not Applicable

Screening Sensitive Protein Markers and Exploring Application in Syndrome Diagnosis of Hot-dampness and Blood Stasis Syndrome in Patients With Rheumatoid Arthritis

Guang'anmen Hospital of China Academy of Chinese Medical Sciences1 site in 1 country90 target enrollmentMay 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Arthritis, Rheumatoid
Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Enrollment
90
Locations
1
Primary Endpoint
serum and saliva protein markers
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to explore the protein markers and to applicate those protein markers in syndrome diagnosis of hot-dampness and blood stasis syndrome in patients with RA.

Detailed Description

RA is one of the main disabling diseases in nowadays, which is an autoimmune disease with complex networks mechanism involving multiple signaling pathways and existing cross path. The investigators consider that the "heat-dampness and blood stasis" syndrome is the main syndrome and major pathogenesis for active RA, which on the base of the theory of traditional Chinese medicine and a large quantity of clinical practice, and also examined by mechanism experiments. But the material basis of this syndrome is remained unclear, lack of high specific objective basis to ensure the syndrome differentiation consistency accurately in clinical practice. Proteomic techniques study cells or the body by all the protein expression and function, thus has the potential efficient for decoding syndrome biological basis. Proteomic techniques are the most effective way to reveal the essence of TCM syndrome. The investigators will use proteomic technology to explore the protein markers and to applicate those protein markers in syndrome diagnosis of hot-dampness and blood stasis syndrome in patients with RA. With strong clinical applicability, this will reveal the scientific connotation of this syndrome, preliminarily guide the syndrome differentiation.

Registry
clinicaltrials.gov
Start Date
May 2015
End Date
December 2017
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Juan Jiao

Attending physician

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Subjects are made or confirmed diagnosis according to the American College of Rheumatology criterion and "heat-dampness and blood stasis" syndrome according to Traditional Chinese Medicine.

Exclusion Criteria

  • Subjects have other serious diseases, such as liver and kidney disease, cerebral-cardio vascular diseases.
  • Subjects, who belong to "non-heat-dampness and blood stasis" syndrome, have double syndrome of heat or dampness.

Outcomes

Primary Outcomes

serum and saliva protein markers

Time Frame: six hours

Study Sites (1)

Loading locations...

Similar Trials